Compare IFF & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IFF | VTR |
|---|---|---|
| Founded | 1833 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 36.3B |
| IPO Year | N/A | 1998 |
| Metric | IFF | VTR |
|---|---|---|
| Price | $65.82 | $79.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | ★ $85.15 | $78.43 |
| AVG Volume (30 Days) | 2.3M | ★ 3.3M |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | ★ 2.45% | 2.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | ★ $11,072,000,000.00 | $5,544,046,000.00 |
| Revenue This Year | N/A | $17.34 |
| Revenue Next Year | N/A | $10.07 |
| P/E Ratio | ★ N/A | $151.48 |
| Revenue Growth | N/A | ★ 16.38 |
| 52 Week Low | $59.14 | $56.68 |
| 52 Week High | $88.09 | $81.89 |
| Indicator | IFF | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 59.05 |
| Support Level | $62.06 | $77.20 |
| Resistance Level | $66.52 | $80.13 |
| Average True Range (ATR) | 1.59 | 1.59 |
| MACD | -0.18 | -0.28 |
| Stochastic Oscillator | 49.36 | 63.65 |
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.